All Blogs
EURUSD faces risk of further move higher after backing off lower prices on Friday. Resistance comes in at the 1.0850 where a break will turn risk towards the 1.0900 level. A breach of here will target the 1.0950 level. Further up, resistance stands at the 1.1000...
The weekly right side is down against the 1/26/2018 highs at .8130. The daily right side is down against the .7029 highs from 12/31/19. While bounces fail below .6445 where the 4 & 1 hour are turning down the pair can continue to see weakness lower...
The weekly is turning down and the daily right side is down with a bearish sequence against the 2/16/18 highs at 1.2568. The 4 hour right side is down with a bearish sequence against the 1.1497 highs from 3/9/20. The hourly right side is down with a bearish sequence against the 1.0993 highs...
As the new world financial crisis keeps going due to the COVID – 19 virus originated in chinal and spreaded all over the world, Mr...
First, a review of last week’s events: - EUR/USD. While in the United States, decisions to allocate money to revive the economy are made quickly enough, in the Euro Zone this is a process that requires a long discussion and agreement between the participating countries...
When I first learnt to trade, I had no clue what I was getting myself into. As I was searching the internet for the wide range of forex material available, I noticed two main things. The first one was 'Forex is the hardest easiest money you will make' and that 'Over 90% of Forex traders fail...
Setup : 1Hour Chart Indicators: Weis Pip Wave, Weis Wave with Alert (+Speed Index) and No Demand No Supply ( https://www.mql5.com/en/users/takisd/seller) Our Story: Look comments on chart. to be continued...
On the earnings side, American Airlines earnings are due today before the opening bell and the latest EPS estimate points at -2.26, like Delta Airlines which has posted its first loss in 9 years earlier this week. Now it is not said that the headline figures will shoot the stock price down...
The US stock markets closed Thursday’s session flat, while Gilead shares tumbled past 4% after the company’s Covid-19 drug remdesivir gave poor clinical results in a Chinese trial according to the Financial Times report based on accidentally released draft documents by the World Health Organizati...
Pivot (invalidation): 15.80 Our preference Long positions above 15.80 with targets at 19.20 & 20.20 in extension. Alternative scenario...
Pivot (invalidation): 15.1000 Our preference Long positions above 15.1000 with targets at 15.3200 & 15.4400 in extension. Alternative scenario...
Pivot (invalidation): 1718.00 Our preference Long positions above 1718.00 with targets at 1731.00 & 1739.00 in extension. Alternative scenario...
Pivot (invalidation): 1.4095 Our preference Short positions below 1.4095 with targets at 1.4040 & 1.3995 in extension. Alternative scenario...
Pivot (invalidation): 2845.00 Our preference Short positions below 2845.00 with targets at 2776.00 & 2726.25 in extension. Alternative scenario...
Pivot (invalidation): 10680.00 Our preference Short positions below 10680.00 with targets at 10320.00 & 10200.00 in extension. Alternative scenario...
Pivot (invalidation): 6.9370 Our preference Long positions above 6.9370 with targets at 7.0000 & 7.0150 in extension. Alternative scenario...
. Pivot (invalidation): 0.6380 Our preference Short positions below 0.6380 with targets at 0.6340 & 0.6325 in extension...
Pivot (invalidation): 0.9745 Our preference Long positions above 0.9745 with targets at 0.9795 & 0.9815 in extension. Alternative scenario...
